Advanced Medical Strategies Welcomes Healthcare Industry Veteran Richard Fuchs to Board of Directors
Boston, MA., January 13, 2025 — Advanced Medical Strategies (AMS), a leading provider of cutting-edge solutions in payment integrity, risk management, and business intelligence, today announced the appointment of Richard Fuchs to its Board of Directors. With over 35 years of leadership experience in the healthcare industry, Mr. Fuchs brings an unparalleled depth of expertise to AMS’s mission to transform healthcare affordability, efficiency, and outcomes.
As a seasoned executive with former leadership roles at Walmart Health & Wellness, Anthem, UnitedHealthcare and HealthNet (Centene), Mr. Fuchs brings expertise in payor relationships, strategic planning, cost containment programs, predictive analytics, and innovative care solutions that will prove invaluable as AMS continues to expand its vision of empowering healthcare organizations to insource Payment Integrity (PI) and Risk Management. Fuchs’s insights into leveraging data-driven strategies align seamlessly with AMS’s flagship PREDICT platform, a comprehensive SaaS solution that enables clients to prevent overpayments, mitigate risks, and improve cost-effectiveness.
“Richard’s deep understanding of the U.S. healthcare ecosystem and his proven ability to lead transformative initiatives make him an exceptional addition to our team,” said Peter Borans, CEO of AMS. “His leadership will help accelerate our efforts to enhance the affordability and effectiveness of healthcare by advancing the insourcing capabilities of our clients.”
“AMS is at the forefront of a pivotal shift in healthcare, leveraging advanced platforms like PREDICT to enable organizations to take control of payment integrity and risk management,” said Fuchs. “I am honored to contribute to this mission and work alongside such a visionary team.”
By advancing the insourcing of PI and Risk Management, AMS equips healthcare organizations to improve claims adjudication accuracy, leverage predictive analytics to identify high-cost claimants, and create preemptive strategies that reduce costs and improve patient outcomes.
Fuch’s addition to the Board of Directors follows a growth investment the company secured in February 2022 from Silversmith Capital Partners.
About AMS
AMS provides cutting-edge software solutions that enhance risk management and decision-making for the healthcare industry. Focused on delivering actionable data, AMS empowers clinical teams, underwriters, and negotiators to optimize cost management, improve claim negotiations, and achieve better health outcomes.
For inquiries: info@amspredict.com
For Media Inquiries: Donna Forsthoffer, dforsthoffer@amspredict.com
